A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/08/2006	EP1718333A2 Methods of modulating cd200 and cd200r
11/08/2006	EP1718328A1 Use of factor xiii for stimulating the perfusion of ischemic tissue
11/08/2006	EP1718326A2 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins
11/08/2006	EP1718325A2 Treatment of bacterial infections
11/08/2006	EP1718324A2 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer's amyloid-beta peptide
11/08/2006	EP1718323A2 Binding peptidomimetics and uses of the same
11/08/2006	EP1718322A2 Antitumor agent
11/08/2006	EP1718321A2 Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
11/08/2006	EP1718318A2 Wound healing composition
11/08/2006	EP1718317A1 Wound healing profile
11/08/2006	EP1718304A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
11/08/2006	EP1718301A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1718289A2 Therapeutic methods employing nitric oxide precursors
11/08/2006	EP1718277A1 Particles for inhalation rapid release properties
11/08/2006	EP1718158A2 Hsp therapy in conjunction with a low antigenicity diet
11/08/2006	EP1502020A4 Stackable low depth tray
11/08/2006	EP1497322A4 Treatment of infections and other disorders
11/08/2006	EP1359934B1 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1335752B1 Multipurpose packages for sterilised products or products to be sterilised
11/08/2006	EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006	EP1248638B1 Use of enoxaparin for the treatment of cerebral ischemia
11/08/2006	EP1237930B1 Chimeric amyloid beta peptides
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	EP0759695B1 A method of inducing an immune response using vaccinia virus recombinants, expressing the gm-csf gene
11/08/2006	CN1860371A Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases
11/08/2006	CN1860364A Fluorescently tagged ligands
11/08/2006	CN1860229A Recombinant protein with cancer suppression action and its encoding gene and use
11/08/2006	CN1860131A Acid soluble proteins from micellar casein
11/08/2006	CN1860129A Novel peptide ligands of leukocyte integrins
11/08/2006	CN1860128A Novel melanocortin receptor agonists
11/08/2006	CN1859943A System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or I
11/08/2006	CN1859851A Mesothelin vaccines and model systems
11/08/2006	CN1857722A Use of cereour bacillus in preparing thrombus treating medicine
11/08/2006	CN1857721A Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method
11/08/2006	CN1857720A Freeze dried human cell fibronection powder and its preparing method
11/08/2006	CN1857719A Skin ulcer treating method
11/08/2006	CN1857718A Nerve growth factor injection
11/08/2006	CN1857717A Anticancer peptide extract of blood clam and its preparing method
11/08/2006	CN1857716A Vancomycin hydrochloride for injection and its preparing method
11/08/2006	CN1857715A Cirrhosis treating medicine
11/08/2006	CN1857714A Slow released antituberculotic preparation
11/08/2006	CN1857713A Osteoporosis treating medicine
11/08/2006	CN1857712A Preparing process of calcium-adding hydrolyzed collagen preparation and its product and application
11/08/2006	CN1857711A Brain protein hydrolysate and production process of its freeze dried preparation
11/08/2006	CN1857699A Medicated pad for preventing and treating hysteromyoma and its preparing method
11/08/2006	CN1857232A Biodegradable nano magnetic capsule loading medicine and its preparing process
11/08/2006	CN1857231A Preparing process of biodegradable capsule loading medicine and nano magnetic particle
11/08/2006	CN1283798C Polypeptides and polynucleotides from coagulase-negative staphylocoui
11/08/2006	CN1283793C Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
11/08/2006	CN1283664C Erythropoietin conjugate
11/08/2006	CN1283659C Truncated glial cell line-derived neurotrophic factor
11/08/2006	CN1283658C Proline ester and preparation containing the same for percutaneous administration
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283652C Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
11/08/2006	CN1283318C Medicinal preparation of slowly-released bioactive substance, its prepn. and application
11/08/2006	CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/08/2006	CN1283314C Antiparkinsonism drugs
11/08/2006	CN1283313C Use of alpha-helix apolipoprotein or HDL-related protein in preparing drugs for prevention and treatment of restenosis by local administration
11/08/2006	CN1283269C Compound preparation of forest frog, and preparation method
11/08/2006	CN1283215C Biodegradable vehicles and delivery systems of biologically active substances
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132530 Oligonucleotides; hybrid nucleic acids; prevent gene expression of superoxide dismutase
11/07/2006	US7132529 Antisense modulation of stearoyl-CoA desaturase expression
11/07/2006	US7132519 Label for use as detection tool in mass spectrometry
11/07/2006	US7132512 Medicament for the treatment of chlamydial infection
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132509 Colon specific gene and protein
11/07/2006	US7132508 Mammalian chemokine reagents
11/07/2006	US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006	US7132504 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132415 Especially a substituted azetidinone compound
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132406 Stimulation of cellular regeneration and differentiation in the inner ear
11/07/2006	US7132405 Targeting vector to the urokinase plasminogen activator receptor
11/07/2006	US7132401 Beta-secretase substrates and uses thereof
11/07/2006	US7132400 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132398 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
11/07/2006	US7132397 Bone morphogenetic protein antagonist based on the mature protein
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006	US7132394 parathyroid hormone (PTH) analogscomprising oligopeptides, useful for the treatment of hypoparathyroidism and bone disorders, such as osteoporosis, and for stimulating repair bone fractures or grafting of implants
11/07/2006	US7132392 administering to mammals peptides having angiostatic activity, that inhibit hepatocyte growth factor induced cell migration and binding between intracellular transducers and receptor protein tyrosine kinases; anticarcinogenic agents
11/07/2006	US7132276 Human p51 genes and gene products thereof
11/07/2006	US7132271 Methods for enhancing the production of viral vaccines in cell culture
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132263 Expression vectors comprising nucleotide sequences coding polypeptides which confer freeze resistance and tolerance; generation and propagation of cold tolerant crop plants
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132260 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
11/07/2006	US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132246 Use of soluble cytokeratin-1-fragments in diagnostics and therapy
11/07/2006	US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics

1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 3163